55 related articles for article (PubMed ID: 38558879)
1. Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date.
Cranmer LD
Onco Targets Ther; 2019; 12():2047-2062. PubMed ID: 30936721
[TBL] [Abstract][Full Text] [Related]
2. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Morbidity and Mortality in Patients with Sarcoma: A Population-Based Study.
Alanazi R; Aljizeeri A; Alsaileek A; Alrashid A; Alolayan A; Alkaiyat M; Alenazy B; Shehata H; Alqahtani J; Ardah H; Alshammari K
Clin Med Insights Oncol; 2024; 18():11795549241237703. PubMed ID: 38558879
[TBL] [Abstract][Full Text] [Related]
4. Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin.
Vitfell-Rasmussen J; Krarup-Hansen A; Vaage-Nilsen M; Kümler T; Zerahn B
Acta Oncol; 2022 Jul; 61(7):801-808. PubMed ID: 35695121
[TBL] [Abstract][Full Text] [Related]
5. Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial.
Jones RL; Wagner AJ; Kawai A; Tamura K; Shahir A; Van Tine BA; Martín-Broto J; Peterson PM; Wright J; Tap WD
Clin Cancer Res; 2021 Jul; 27(14):3861-3866. PubMed ID: 33632930
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Safety of Pegylated Liposomal Doxorubicin After Conventional Doxorubicin Exposure in Patients With Sarcoma and Breast Cancer.
Alhaja M; Chen S; Chin AC; Schulte B; Legasto CS
Cureus; 2023 Sep; 15(9):e44837. PubMed ID: 37809186
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline-induced cardiotoxicity in patients with paediatric bone sarcoma and soft tissue sarcoma.
Bini I; Asaftei SD; Riggi C; Tirtei E; Manicone R; Biasin E; Basso ME; Agnoletti G; Fagioli F
Cardiol Young; 2017 Nov; 27(9):1815-1822. PubMed ID: 28780919
[TBL] [Abstract][Full Text] [Related]
8. The burden and predictors of venous thromboembolic diseases in patients with multiple primary malignancies.
Alhamadh MS; Alanazi RB; Alqirnas MQ; Alhabeeb AY; Chachar YS; Alkaiyat M; Sabatin F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1742. PubMed ID: 36314077
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue sarcoma: Recognizing a rare disease.
Ardakani AHG; Woollard A; Ware H; Gikas P
Cleve Clin J Med; 2022 Feb; 89(2):73-80. PubMed ID: 35105695
[TBL] [Abstract][Full Text] [Related]
10. Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.
Jeong H; Im HS; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Kim JE; Ahn JH
Cancer Manag Res; 2021; 13():8795-8802. PubMed ID: 34853534
[TBL] [Abstract][Full Text] [Related]
11. High cumulative doxorubicin dose for advanced soft tissue sarcoma.
Tian Z; Yang Y; Yang Y; Zhang F; Li P; Wang J; Yang J; Zhang P; Yao W; Wang X
BMC Cancer; 2020 Nov; 20(1):1139. PubMed ID: 33228579
[TBL] [Abstract][Full Text] [Related]
12. Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.
Gamboa AC; Gronchi A; Cardona K
CA Cancer J Clin; 2020 May; 70(3):200-229. PubMed ID: 32275330
[TBL] [Abstract][Full Text] [Related]
13. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry.
López-Sendón J; Álvarez-Ortega C; Zamora Auñon P; Buño Soto A; Lyon AR; Farmakis D; Cardinale D; Canales Albendea M; Feliu Batlle J; Rodríguez Rodríguez I; Rodríguez Fraga O; Albaladejo A; Mediavilla G; González-Juanatey JR; Martínez Monzonis A; Gómez Prieto P; González-Costello J; Serrano Antolín JM; Cadenas Chamorro R; López Fernández T
Eur Heart J; 2020 May; 41(18):1720-1729. PubMed ID: 32016393
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy.
Tzolos E; Adamson PD; Hall PS; Macpherson IR; Oikonomidou O; MacLean M; Lewis SC; McVicars H; Newby DE; Mills NL; Lang NN; Henriksen PA
Clin Oncol (R Coll Radiol); 2020 May; 32(5):292-297. PubMed ID: 31813662
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
